AVALO THERAPEUTICS INC

AVTXNASDAQ

🏆 #3029 by market capEarnings Nov 4US Equity

$7.44▲ $0.32 (+4.49%)

🌙 After hours$7.28▼ 2.15%Regular close · extended-hours price shown

🔔

Track AVTX

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 4.5%

7d▲ 7.3%

14d▼ 34.0%

30d▼ 51.4%

ytd▼ 59.0%

1y▼ 58.7%

🏦Market Cap

$399M

Small Cap

📈Revenue Growth (YoY)

-86.6%

Declining

📊Gross Margin

-16861.0%

Thin

💵FCF Margin

-112505.1%

Thin

⚖️P/S Ratio

6762.8x

Expensive

Otter Score

Weak

AVALO THERAPEUTICS INC

AVTX

Analyst Ratings

Price

$7.44

Total

Raised

Lowered

Avg PT

$35.13

H / L

$60 / $10

Institution	Action	Rating	Date		Upside
Guggenheim	Downgraded	Buy → Neutral	2026-10-23	$48.00	+545.20%
Wedbush	Reiterated	Outperform	2026-10-23	$34.00	+357.00%
HC Wainwright & Co.	Downgraded	Buy → Neutral	2026-10-23	—	—
BTIG	Reiterated	Buy	2026-10-23	$10.00	+34.40%
Mizuho	Reiterated	Outperform	2026-05-14	—	—
Citizens	Reiterated	Market Outperform	2026-05-14	—	—
Piper Sandler	Reiterated	Overweight	2026-05-11	$60.00	+706.50%
Oppenheimer	Upgraded	Perform → Outperform	2024-04-16	$16.00	+115.10%
RBC Capital	Downgraded	Outperform → Sector Perform	2023-06-26	—	—
Jefferies	Downgraded	Hold → Underperform	2023-02-07	$23.00	+209.10%

Institution

Guggenheim

Downgraded · Buy → Neutral · 2026-10-23

$48.00

+545.20%

Wedbush

Reiterated · Outperform · 2026-10-23

$34.00

+357.00%

HC Wainwright & Co.

Downgraded · Buy → Neutral · 2026-10-23

—

BTIG

Reiterated · Buy · 2026-10-23

$10.00

+34.40%

Mizuho

Reiterated · Outperform · 2026-05-14

—

Citizens

Reiterated · Market Outperform · 2026-05-14

—

Piper Sandler

Reiterated · Overweight · 2026-05-11

$60.00

+706.50%

Oppenheimer

Upgraded · Perform → Outperform · 2024-04-16

$16.00

+115.10%

RBC Capital

Downgraded · Outperform → Sector Perform · 2023-06-26

—

Jefferies

Downgraded · Hold → Underperform · 2023-02-07

$23.00

+209.10%

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space